Literature DB >> 30450618

Key pathway and gene alterations in the gastric mucosa associated with obesity and obesity-related diabetes.

Xin Wen1,2,3, Chunhua Qian1,2,3, Yi Zhang4, Ruijin Wu5, Liesheng Lu6, Cuiling Zhu1,2,3, Xiaoyun Cheng1,2,3, Rai Cui1,2,3, Hui You1,2,3, Fangyun Mei1,2,3, Jingyang Gao1,2,3, Feng Li1,2,3, Le Bu1,2,3, Shen Qu1,2,3.   

Abstract

BACKGROUND AND
OBJECTIVE: The stomach plays an important role in obesity and obesity-related diabetes; yet, little is known about key pathways in the gastric mucosa associated with obesity and diabetes.
METHODS: We performed gene microarray and real time-polymerase chain reaction (RT-PCR) on gut mucosa samples from control subjects (CON), patients with simple obesity (OB), and patients with obesity and comorbid diabetes (OD) (n = 3 per group). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were used to predict the functional significance of differentially expressed genes.
RESULTS: In total, 262 genes were upregulated and 265 genes were downregulated in the OB group whereas 1756 genes were upregulated and 1053 genes were downregulated in the OD group compared with the CON group. Of these, 23 were co-regulated in both comparisons. Seven differentially expressed genes were validated by RT-PCR (NRIP3, L1CAM, TPO, P2RY1, OR8A1, ADAMTS19, and ASIC3). A functional analysis revealed that genes differentially expressed between the OB or OD and CON groups played crucial roles in metabolic, T cell, and G-protein coupled receptor biological processes, and primarily participated in the PI3K-Akt and AGE-RAGE signaling pathways.
CONCLUSIONS: Obesity and obesity-related diabetes are associated with important gene expression and pathway alterations in the stomach.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  gastric mucosa; gene microarray; obesity; type 2 diabetes mellitus (T2DM)

Mesh:

Substances:

Year:  2018        PMID: 30450618     DOI: 10.1002/jcb.27976

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1.

Authors:  Nicolás G Simonet; Joshua K Thackray; Berta N Vazquez; Alessandro Ianni; Maria Espinosa-Alcantud; Julia Morales-Sanfrutos; Sarah Hurtado-Bagès; Eduard Sabidó; Marcus Buschbeck; Jay Tischfield; Carolina De La Torre; Manel Esteller; Thomas Braun; Mireia Olivella; Lourdes Serrano; Alejandro Vaquero
Journal:  Sci Adv       Date:  2020-07-24       Impact factor: 14.136

2.  Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules.

Authors:  G Prashanth; Basavaraj Vastrad; Anandkumar Tengli; Chanabasayya Vastrad; Iranna Kotturshetti
Journal:  BMC Endocr Disord       Date:  2021-04-26       Impact factor: 2.763

3.  Decoding the chemical composition and pharmacological mechanisms of Jiedu Tongluo Tiaogan Formula using high-performance liquid chromatography coupled with network pharmacology-based investigation.

Authors:  Qi Zhang; Chunli Piao; Wenqi Jin; Han Wang; Cheng Tang; Xiaohua Zhao; Naiwen Zhang; Shengnan Gao; Fengmei Lian
Journal:  Aging (Albany NY)       Date:  2021-11-05       Impact factor: 5.682

4.  NRIP3 upregulation confers resistance to chemoradiotherapy in ESCC via RTF2 removal by accelerating ubiquitination and degradation of RTF2.

Authors:  Daqin Suo; Ling Wang; Tingting Zeng; Hui Zhang; Lei Li; Jinyun Liu; Jingping Yun; Xin-Yuan Guan; Yan Li
Journal:  Oncogenesis       Date:  2020-08-24       Impact factor: 7.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.